Menu
GWAS Study

Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease.

Hoggart C, Shimizu C, Galassini R et al.

33772158 PubMed ID
GWAS Study Type
8456 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HC
Hoggart C
SC
Shimizu C
GR
Galassini R
WV
Wright VJ
SH
Shailes H
BE
Bellos E
HJ
Herberg JA
PA
Pollard AJ
OD
O'Connor D
CS
Choi SW
SE
Seaby EG
MS
Menikou S
HM
Hibberd M
SN
Sallah N
BD
Burgner D
BP
Brogan P
PH
Patel H
KJ
Kim J
TA
Tremoulet AH
SE
Salo E
VS
van Stijn D
KT
Kuijpers T
BJ
Burns JC
LM
Levin M
Chapter II

Abstract

Summary of the research findings

Kawasaki disease (KD) is a paediatric vasculitis associated with coronary artery aneurysms (CAA). Genetic variants influencing susceptibility to KD have been previously identified, but no risk alleles have been validated that influence CAA formation. We conducted a genome-wide association study (GWAS) for CAA in KD patients of European descent with 200 cases and 276 controls. A second GWAS for susceptibility pooled KD cases with healthy paediatric controls from vaccine trials in the UK (n = 1609). Logistic regression mixed models were used for both GWASs. The susceptibility GWAS was meta-analysed with 400 KD cases and 6101 controls from a previous European GWAS, these results were further meta-analysed with Japanese GWASs at two putative loci. The CAA GWAS identified an intergenic region of chromosome 20q13 with multiple SNVs showing genome-wide significance. The risk allele of the most associated SNV (rs6017006) was present in 13% of cases and 4% of controls; in East Asian 1000 Genomes data, the allele was absent or rare. Susceptibility GWAS with meta-analysis with previously published European data identified two previously associated loci (ITPKC and FCGR2A). Further meta-analysis with Japanese GWAS summary data from the CASP3 and FAM167A genomic regions validated these loci in Europeans showing consistent effects of the top SNVs in both populations. We identified a novel locus for CAA in KD patients of European descent. The results suggest that different genes determine susceptibility to KD and development of CAA and future work should focus on the function of the intergenic region on chromosome 20q13.

400 European ancestry cases, 6,101 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

8456
Total Participants
GWAS
Study Type
Yes
Replicated
346 European ancestry cases, 1,609 European ancestry controls
Replication Participants
European
Ancestry
Netherlands, U.S., U.K., Finland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.